Financials in USD. Standardized financial statements.
A compact view of how PURE Bioscience, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.20M | $1.96M | $1.88M | $1.85M | $3.93M | $6.92M | $1.91M | $1.77M | $1.83M | $1.29M |
| Revenue Growth? | +12.2% | +4.6% | +1.3% | -52.8% | -43.2% | +262.3% | +7.6% | -3.1% | +42.0% | 0.0% |
| Cost of Revenue? | $899,000 | $811,000 | $906,000 | $853,000 | $1.85M | $2.90M | $728,000 | $763,000 | $760,000 | $441,000 |
| Gross Profit? | $1.30M | $1.15M | $971,000 | $1.00M | $2.08M | $4.02M | $1.18M | $1.01M | $1.07M | $848,000 |
| Gross Margin? | +59.2% | +58.7% | +51.7% | +54.0% | +52.8% | +58.1% | +61.9% | +57.0% | +58.5% | +65.8% |
| Operating Expenses? | $3.58M | $4.34M | $4.60M | $4.42M | $4.39M | $4.02M | $6.77M | $8.05M | $7.08M | $7.91M |
| Operating Income? | -$2.27M | -$3.13M | -$3.94M | -$3.42M | -$2.31M | $9,000 | -$5.59M | -$7.04M | -$6.01M | $247,000 |
| EBITDA? | -$2.10M | -$3.05M | -$3.83M | -$3.27M | -$2.14M | $201,000 | -$6.31M | -$7.15M | -$5.99M | -$14.14M |
| Income Before Tax | -$2.40M | -$3.35M | -$3.96M | -$3.49M | -$2.32M | $4,000 | -$6.55M | -$7.44M | -$6.26M | -$14.37M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $7,000 | $33,000 | $255,000 | $7.31M |
| Net Income? | -$2.40M | -$3.35M | -$3.96M | -$3.50M | -$2.32M | -$6,000 | -$6.56M | -$7.47M | -$6.52M | -$21.68M |
| EPS? | $-0.02 | $-0.03 | $-0.04 | $-0.04 | $-0.03 | $-0.00 | $-0.09 | $-0.11 | $-0.10 | $-0.38 |
| Diluted EPS? | $-0.02 | $-0.03 | $-0.04 | $-0.04 | $-0.03 | $-0.00 | $-0.09 | $-0.11 | $-0.10 | $-0.38 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality